The relationship between P16INK4A and TP53 promoter methylation and the risk and prognosis in patients with oesophageal cancer in Thailand |…

Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209249 (2021).

PubMed Article Google Scholar

Chao, Y. K. et al. Factors associated with survival in patients with oesophageal cancer who achieve pathological complete response after chemoradiotherapy: A nationwide population-based study. Eur. J. Cardiothorac. Surg. 51(1), 155159 (2017).

PubMed Article Google Scholar

Imsamran, W., Chaiwerawattana, A., Wiangnon, S., Pongnikorn, D., Suwangrungrung, K., Sangrajrang S. & Buasom R. (eds.). Cancer in Thailand, Vol. VIII, 20102012. (Bangkok Medical Publisher, 2015).

Ghobadi, N. et al. A genetic variant in CDKN2A/2B locus was associated with poor prognosis in patients with esophageal squamous cell carcinoma. J. Cell Physiol. 234(4), 50705076 (2019).

CAS PubMed Article Google Scholar

Zhao, R., Choi, B. Y., Lee, M. H., Bode, A. M. & Dong, Z. Implications of genetic and epigenetic alterations of CDKN2A (p16(INK4a)) in cancer. EBioMedicine 8, 3039 (2016).

PubMed PubMed Central Article Google Scholar

Wang, S., Pan, D., Su, M., Huang, G. & Sun, G. Moderately high folate level may offset the effects of aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and precancerous lesions. Genes Nutr. 15(1), 18 (2020).

PubMed PubMed Central Article CAS Google Scholar

Zhou, C. et al. The association and clinical significance of CDKN2A Promoter methylation in head and neck squamous cell carcinoma: a meta-analysis. Cell Physiol. Biochem. 50, 868882 (2018).

CAS PubMed Article Google Scholar

Pan, D. et al. MTHFR C677T genetic polymorphism in combination with serum vitamin B2, B12 and aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and esophageal precancerous lesions: A casecontrol study. Cancer Cell Int. 19, 288 (2019).

PubMed PubMed Central Article CAS Google Scholar

Wang, T. H., Hsia, S. M., Shih, Y. H. & Shieh, T. M. Association of smoking, alcohol use, and betel quid chewing with epigenetic aberrations in cancers. Int. J. Mol. Sci. 18(6), 1210 (2017).

PubMed Central Article CAS Google Scholar

Talukdar, F. R., Ghosh, S. K., Laskar, R. S. & Mondal, R. Epigenetic, genetic and environmental interactions in esophageal squamous cell carcinoma from northeast India. PLoS ONE 8(4), e60996 (2013).

ADS CAS PubMed PubMed Central Article Google Scholar

Li, D. et al. Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer. Aging 11(23), 1164011658 (2019).

CAS PubMed PubMed Central Article Google Scholar

Ma, K., Cao, B. & Guo, M. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma. Clin. Epigenetics 8, 43 (2016).

PubMed PubMed Central Article CAS Google Scholar

Lopes, N., Correia, M. P., Henrique, R. & Jernimo, C. Epigenetic alterations in esophageal cancer: expression and role of the involved enzymes. Int. J. Mol. Sci. 21(10), 3522 (2020).

CAS PubMed Central Article Google Scholar

Lin, L., Cheng, X. & Yin, D. Aberrant DNA methylation in esophageal squamous cell carcinoma: biological and clinical implications. Front. Oncol. 10, 549850 (2020).

PubMed PubMed Central Article Google Scholar

Das, M. et al. P16 hypermethylation: a biomarker for increased esophageal cancer susceptibility in high incidence region of North East India. Tumour Biol. 36(3), 16271642 (2015).

CAS PubMed Article Google Scholar

Jesionek-Kupnicka, D. et al. TP53 promoter methylation in primary glioblastoma: Relationship with TP53 mRNA and protein expression and mutation status. DNA Cell Biol. 33(4), 217226 (2014).

CAS PubMed PubMed Central Article Google Scholar

Kajiura, K. et al. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma. Oncotarget 8(2), 28902905 (2017).

PubMed Article Google Scholar

Zhou, C. et al. DNA methylation biomarkers for head and neck squamous cell carcinoma. Epigenetics 13(4), 398409 (2018).

PubMed PubMed Central Article Google Scholar

Nanok, C., Jearanaikoon, P., Proungvitaya, S. & Limpaiboon, T. Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma. Mol Med Rep. 17(3), 41454153 (2018).

CAS PubMed Google Scholar

Yatagai, N. et al. TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation. Virchows Arch. 474(3), 315324 (2019).

CAS PubMed Article Google Scholar

Chang, H. W., Ling, G. S., Wei, W. I. & Yuen, A. P. Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma. Cancer 101(1), 125132 (2004).

PubMed Article Google Scholar

Ghantous, Y., Schussel, J. L. & Brait, M. Tobacco and alcohol-induced epigenetic changes in oral carcinoma. Curr. Opin. Oncol. 30(3), 152158 (2018).

CAS PubMed PubMed Central Article Google Scholar

Xie, W. et al. Relationship between DLEC1 and PBX3 promoter methylation and the risk and prognosis of gastric cancer in peripheral blood leukocytes. J. Cancer Res. Clin. Oncol. 146(5), 11151124 (2020).

CAS PubMed Article Google Scholar

Takeshima, H. & Ushijima, T. Accumulation of genetic and epigenetic alterations in normal cells and cancer risk. npj Precis. Oncol. https://doi.org/10.1038/s41698-019-0079-0 (2019).

Article PubMed PubMed Central Google Scholar

Shao, Y., Jiang, H., Wu, X., Luo, Y. & Tang, W. P16 promoter hypermethylation is associated with increased risk of nasopharyngeal carcinoma. Mol. Clin. Oncol. https://doi.org/10.3892/mco.2014.396 (2014).

Article PubMed PubMed Central Google Scholar

Das, M. et al. P16 gene silencing along with p53 single-nucleotide polymorphism and risk of esophageal cancer in Northeast India. Tumour Biol. https://doi.org/10.1177/1010428317698384 (2017).

Article PubMed Google Scholar

Guo, M. et al. Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus. Clin. Cancer Res. 12(15), 45154522 (2006).

CAS PubMed Article Google Scholar

Xu, R., Wang, F., Wu, L., Wang, J. & Lu, C. A systematic review of hypermethylation of p16 gene in esophageal cancer. Cancer Biomark. 13(4), 215226 (2013).

PubMed Article CAS Google Scholar

Abbaszadegan, M. R. et al. Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma. Int. J. Gastrointest. Cancer 36(1), 4754 (2005).

CAS PubMed Article Google Scholar

Baba, Y., Watanabe, M. & Baba, H. Review of the alterations in DNA methylation in esophageal squamous cell carcinoma. Surg. Today. 43(12), 13551364 (2013).

CAS PubMed Article Google Scholar

Wang, J. et al. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma. Cancer Epidemiol. Biomark. Prev. 17(1), 118125 (2008).

CAS Article Google Scholar

Oka, D. et al. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: A target for risk diagnosis and prevention of esophageal cancers. Cancer 115(15), 34123426 (2009).

CAS PubMed Article Google Scholar

Toh, Y. et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int. J. Clin. Oncol. 15(2), 135144 (2010).

CAS PubMed Article Google Scholar

Fujiwara, S. et al. Hypermethylation of p16 gene promoter correlates with loss of p16 expression that results in poorer prognosis in esophageal squamous cell carcinomas. Dis. Esophagus 21(2), 125131 (2008).

CAS PubMed Article Google Scholar

Limpaiboon, T. et al. P53 status and human papillomavirus infection in Thai women with cervical carcinoma. Southeast Asian J. Trop. Med. Public Health 31(1), 6671 (2000).

CAS PubMed Google Scholar

Abat, D. et al. Genetic alterations of chromosomes, p53 and p16 genes in low- and high-grade bladder cancer. Oncol. Lett. 8(1), 2532 (2014).

PubMed PubMed Central Article Google Scholar

Fagundes, R. B., Mello, C. R. & Tollens, P. P53 protein in esophageal mucosa of individuals at high risk of squamous cell carcinoma of the esophagus. Dis. Esophagus 14, 185190 (2001).

CAS PubMed Article Google Scholar

Lima, E. M. et al. Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer. Braz. J. Med. Biol. Res. 41(6), 539543 (2008).

CAS PubMed Article Google Scholar

Zhao, L. J. et al. Association of p53 Arg72Pro polymorphism with esophageal cancer: A meta-analysis based on 14 case control studies. Genet. Test. Mol. Biomarkers 17, 721726 (2013).

CAS PubMed Article Google Scholar

Samareh-Fekri, M. et al. Detection of Helicobacter pylori in the bronchoalveolar lavage of patients with lung cancer using real-time PCR. Jundishapur J. Microbiol. 9(11), e32144 (2016).

PubMed PubMed Central Article CAS Google Scholar

Zhou, C., Li, J. & Li, Q. CDKN2A methylation in esophageal cancer: A meta-analysis. Oncotarget 8(30), 5007150083 (2017).

PubMed PubMed Central Article Google Scholar

Huang, Y. et al. Cigarette smoke induces promoter methylation of single-stranded DNA-binding protein 2 in human esophageal squamous cell carcinoma. Int. J. Cancer 128(10), 22612273 (2011).

CAS PubMed PubMed Central Article Google Scholar

Ye, F. & Xu, X. C. Benzo[a]pyrene diol epoxide suppresses retinoic acid receptor-beta2 expression by recruiting DNA (cytosine-5-)-methyltransferase 3A. Mol. Cancer 9, 93 (2010).

PubMed PubMed Central Article CAS Google Scholar

Warnakulasuriya, S. & Straif, K. Carcinogenicity of smokeless tobacco: Evidence from studies in humans & experimental animals. Indian J. Med. Res. 148(6), 681686 (2018).

CAS PubMed PubMed Central Article Google Scholar

Anantharaman, D. et al. Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer. Oral Oncol. 47(8), 725731 (2011).

PubMed Article Google Scholar

Yang, X. et al. Smoking and alcohol drinking in relation to the risk of esophageal squamous cell carcinoma: A population-based case-control study in China. Sci .Rep. 7(1), 17249 (2017).

ADS PubMed PubMed Central Article CAS Google Scholar

Fan, Y., Yuan, J. M., Wang, R., Gao, Y. T. & Yu, M. C. Alcohol, tobacco, and diet in relation to esophageal cancer: The Shanghai Cohort Study. Nutr. Cancer 60(3), 354363 (2008).

PubMed PubMed Central Article Google Scholar

Da Costa, A. M. et al. HPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors. Infect. Agent Cancer 12, 54 (2017).

PubMed PubMed Central Article CAS Google Scholar

Aghcheli, K. et al. Prognostic factors for esophageal squamous cell carcinomaa population-based study in Golestan Province, Iran, a high incidence area. PLoS ONE 6(7), e22152 (2011).

ADS CAS PubMed PubMed Central Article Google Scholar

Fujiwara, S. et al. Hypermethylation of p16 gene promoter correlates with loss of p16 expression that results in poorer prognosis in esophageal squamous cell carcinomas. Dis. Esophagus. 21(2), 125131 (2008).

CAS PubMed Article Google Scholar

Li, F. et al. Targeting epigenetic aberrations in esophageal squamous cell carcinoma. Curr. Pharmacol. Rep. 6, 415428 (2020).

Go here to read the rest:
The relationship between P16INK4A and TP53 promoter methylation and the risk and prognosis in patients with oesophageal cancer in Thailand |...